診斷專用酵素市場 - 產品（聚合酶和核酸酶、蛋白酶、氧化酶、糖酶）、應用（臨床化學[血糖監測、POC 測試]、免疫測定、分子診斷） - 全球預測（2024 - 2032）

Diagnostic Specialty Enzymes Market - Product (Polymerases and Nucleases, Proteases, Oxidases, Carbohydrase), Application (Clinical Chemistry [Blood Glucose Monitoring, POC Testing], Immunoassay, Molecular Diagnostics) - Global Forecast (2024 - 2032)

出版日期: 2024年05月28日 | 出版商:

Global Market Insights Inc. | 英文 82 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於需要精確和早期檢測的慢性和傳染病日益流行，預計診斷專用酶市場規模從 2024 年到 2032 年將實現 8.1% 的複合年成長率。報告表明，全世界有三分之一的成年人患有多種慢性病。隨著全球人口老化，癌症、糖尿病和心血管疾病等疾病的發病率不斷上升，對能夠提供準確、快速結果的先進診斷工具的需求不斷成長。

分子診斷、個人化醫療和即時檢測的創新也推動了對專用酵素的需求，以促進複雜的檢測並提高診斷準確性。家庭檢測的興起以及對預防性醫療保健的日益關注也推動了市場的擴張。

診斷專用酵素產業分為產品、應用和區域。

就產品而言，氧化酶領域預計在 2024 年至 2032 年間大幅成長。氧化酶技術的進步提高了穩定性和反應特異性，加上對現場護理和家庭診斷解決方案不斷成長的需求，將進一步促進該領域的成長。

在應用方面，由於其廣泛應用於檢測各種具有高特異性和敏感性的疾病和病症，到2032年，免疫分析領域的診斷特種酶市場將顯著成長。免疫測定依賴於酶聯免疫吸附測定 (ELISA) 和其他基於酶的檢測方法，對於準確的疾病診斷和監測至關重要。

亞太地區診斷特種酵素產業預計將在 2024 年至 2032 年期間實現大幅擴張。對個人化醫療的關注和對早期疾病檢測的日益重視也是推動區域產品採用的關鍵驅動力。

產業生態系統分析
產業影響力
- 成長動力
  - 分子診斷測試的成長
  - 對慢性病及時診斷的需求不斷增加
  - 快速採用現場護理測試技術
  - 酵素生產技術的進展
- 產業陷阱與挑戰
  - 嚴格的監管要求
  - 對產品品質和安全的擔憂
成長潛力分析
未來市場趨勢
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
聚合酶和核酸酶
蛋白酶
氧化酶
醣酶
其他產品

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
分子診斷
免疫分析
臨床化學
- 血糖監測
- POC測試
- 其他臨床化學測試
其他應用

第 7 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Agilent Technologies, Inc.
Amano Enzymes Inc.
American Laboratories, Inc.
BBI Solutions
Biocatalysts Ltd. (BRAIN Biotech Group)
Bio-Rad Laboratories, Inc.
Codexis, Inc.
F. Hoffmann-La Roche Ltd.
Merck KGaA
New England Biolabs
Novozymes A/S
QIAGEN
SEKISUI Diagnostics
Takara Bio Inc.
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 9686

Diagnostic specialty enzymes market size is anticipated to observe an 8.1% CAGR from 2024 to 2032, driven by the increasing prevalence of chronic and infectious diseases that require precise and early detection. Reports indicate that 1 in 3 adults worldwide suffer from multiple chronic conditions. As the global population is aging and the incidence of diseases like cancer, diabetes, and cardiovascular conditions is rising, there is growing demand for advanced diagnostic tools that can provide accurate and rapid results.

Innovations in molecular diagnostics, personalized medicine, and point-of-care testing are also driving the demand for specialized enzymes to facilitate complex assays and improve diagnostic accuracy. The rise of home-based testing and the increasing focus on preventive healthcare are also driving the market expansion.

The diagnostic specialty enzymes industry is segmented into product, application, and region.

With respect to product, the oxidases segment is poised for substantial growth from 2024 to 2032. Oxidases play a pivotal role in a variety of high-precision diagnostic assays and biosensors, such as glucose monitoring in diabetes management as well as, detecting pathogens and metabolic disorders. Advancements in oxidase enzyme technology for enhancing stability and reaction specificity, coupled with the rising demand for point-of-care and home-based diagnostic solutions will further bolster the segment growth.

In terms of application, the diagnostic specialty enzymes market from the immunoassays segment will grow significantly through 2032 owing to its widespread application in detecting a variety of diseases and conditions with high specificity and sensitivity. Immunoassays, which rely on enzyme-linked immunosorbent assays (ELISA) and other enzyme-based detection methods, are crucial for accurate disease diagnosis and monitoring.

Asia Pacific diagnostic specialty enzymes industry is primed for significant expansion from 2024 to 2032. This growth is attributed to the increasing healthcare needs, the rising prevalence of chronic and infectious diseases, along with rapid advancements in diagnostic technologies. The focus on personalized medicine and the growing emphasis on early disease detection are also key drivers driving the regional product adoption.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growth in molecular diagnostic tests
  - 3.2.1.2 Increasing demand for timely diagnosis of chronic diseases
  - 3.2.1.3 Rapid adoption of point of care testing technologies
  - 3.2.1.4 Advances in enzyme production technology
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory requirements
  - 3.2.2.2 Concerns related to product quality and safety
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Polymerases and nucleases
5.3 Proteases
5.4 Oxidases
5.5 Carbohydrase
5.6 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Molecular diagnostics
6.3 Immunoassay
6.4 Clinical chemistry
- 6.4.1 Blood glucose monitoring
- 6.4.2 POC testing
- 6.4.3 Other clinical chemistry tests
6.5 Other applications

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa